Page 3 - Thomasm Soloway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. T-knife Therapeutics Announces the Appointment of Donald Wuchterl as Senior Vice President and ... AKAMPIONApril 7, 2021 GMT San Francisco, CA / Berlin, Germany – April 7, 2021 — T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing innovative therapeutics for the benefit of solid tumor patients and their families, today announced the appointment of Donald Wuchterl as Senior Vice President and Chief Manufacturing Officer. In this newly appointed role, Mr. Wuchterl will...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. ... AKAMPIONJanuary 19, 2021 GMT San Francisco, CA / Berlin, Germany – January 19, 2021 — T-knife GmbH, a next-generation adoptive T-cell therapy company leveraging its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, today announced the appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer....